COCP Fundamental Analysis - COCRYSTAL PHARMA INC

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to COCP. COCP was compared to 193 industry peers in the Pharmaceuticals industry. No worries on liquidiy or solvency for COCP as it has an excellent financial health rating, but there are worries on the profitability. COCP does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

COCP had negative earnings in the past year.

In the past year COCP has reported a negative cash flow from operations.

In the past 5 years COCP always reported negative net income.

In the past 5 years COCP always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of COCP (-148.66%) is worse than 83.94% of its industry peers.

Looking at the Return On Equity, with a value of -216.95%, COCP is doing worse than 71.50% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-148.66%
ROE	-216.95%
ROIC	N/A

ROA(3y)-95.52%

ROA(5y)-64.44%

ROE(3y)-118.44%

ROE(5y)-78.4%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

COCP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for COCP remains at a similar level compared to 1 year ago.

COCP has more shares outstanding than it did 5 years ago.

There is no outstanding debt for COCP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

COCP has an Altman-Z score of -45.02. This is a bad value and indicates that COCP is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of COCP (-45.02) is worse than 90.67% of its industry peers.

COCP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-45.02

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

COCP has a Current Ratio of 4.57. This indicates that COCP is financially healthy and has no problem in meeting its short term obligations.

With a decent Current ratio value of 4.57, COCP is doing good in the industry, outperforming 66.84% of the companies in the same industry.

A Quick Ratio of 4.57 indicates that COCP has no problem at all paying its short term obligations.

COCP has a better Quick ratio (4.57) than 68.39% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	4.57
Quick Ratio	4.57

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

COCP shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.85%.

EPS 1Y (TTM)4.85%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%41.03%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, COCP will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.93% on average per year.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y37.31%

EPS Next 2Y14.72%

EPS Next 3Y8.93%

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

COCP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year COCP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y14.72%

EPS Next 3Y8.93%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for COCP!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

COCRYSTAL PHARMA INC

NASDAQ:COCP (7/11/2025, 8:01:23 PM)

Premarket: 1.76 -0.04 (-2.22%)

1.8

+0.23 (+14.65%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)05-15 2025-05-15/bmo

Earnings (Next)08-12 2025-08-12/bmo

Inst Owners7.36%

Inst Owner Change0%

Ins Owners16.93%

Ins Owner Change0%

Market Cap18.31M

Analysts82.5

Price Target8.5 (372.22%)

Short Float %0.07%

Short Ratio0.23

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)48.08%

Min EPS beat(2)40.81%

Max EPS beat(2)55.35%

EPS beat(4)3

Avg EPS beat(4)25.72%

Min EPS beat(4)-9.01%

Max EPS beat(4)55.35%

EPS beat(8)7

Avg EPS beat(8)26.83%

EPS beat(12)9

Avg EPS beat(12)-21.76%

EPS beat(16)11

Avg EPS beat(16)-17.58%

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)6.25%

EPS NQ rev (3m)43.93%

EPS NY rev (1m)49.24%

EPS NY rev (3m)50.77%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	2.51
P/tB	2.51
EV/EBITDA	N/A

EPS(TTM)-1.57

EYN/A

EPS(NY)-1.18

Fwd EYN/A

FCF(TTM)-1.46

FCFYN/A

OCF(TTM)-1.46

OCFYN/A

SpS0

BVpS0.72

TBVpS0.72

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-148.66%
ROE	-216.95%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-95.52%

ROA(5y)-64.44%

ROE(3y)-118.44%

ROE(5y)-78.4%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	1.8%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	4.57
Quick Ratio	4.57
Altman-Z	-45.02

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)35.21%

Cap/Depr(5y)56.39%

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)4.85%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%41.03%

EPS Next Y37.31%

EPS Next 2Y14.72%

EPS Next 3Y8.93%

EPS Next 5YN/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y20.5%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year15.27%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y28.67%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y28.25%

OCF growth 3YN/A

OCF growth 5YN/A

COCRYSTAL PHARMA INC (COCP) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens